Mixed response to latest Solidarity trial COVID findings No therapeutics in the trial – including remdesivir – were found to affect on mortality or illness duration, but some say there is hope.
Gold standard trial finds remdesivir shortens duration of COVID-19 The results have confirmed doctors’ experiences of treating COVID patients in Australia.
US purchasing global supply of COVID-19 drug raises ethical questions Gilead Sciences has donated a supply of remdesivir to Australia’s national medical stockpile. But what if cases continue to rise?
Antiviral becomes first recommended treatment for COVID-19 newsGP speaks with the Chair of Australia’s National Covid-19 Clinical Evidence Taskforce about the recommended use of remdesivir.
Remdesivir under review by national COVID-19 taskforce newsGP speaks to taskforce Chair Associate Professor Julian Elliott about the latest guidance for the care of coronavirus patients.
Remdesivir and COVID-19: What GPs need to know It has become the first therapy for COVID-19 to receive FDA approval for emergency use – but evidence of its effectiveness remains mixed.